CME in Minutes: Education in Dermatology
Peter Lio, MD - Clinical Perspective on the Latest Data for Emerging Therapies Targeting IL-13 in Moderate-to-Severe Atopic Dermatitis
02 Sep 2022
Please visit answersincme.com/KVB860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in dermatology discusses the impact of emerging biologics on the treatment of moderate-to-severe atopic dermatitis (AD). Upon completion of this activity, participants should be better able to: Discuss the latest efficacy and safety data for emerging biologic agents that target interleukin (IL)-13 cytokines for moderate-to-severe AD; and Outline how the latest data may inform the future use of emerging biologic agents that target IL-13 cytokines for moderate-to-severe AD within the context of the current treatment landscape.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
13:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
10:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
13:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana